The two year study, that took four years, in those four years, patients proved ATI to be a far superior product, compared to surgery
Addressable market has only gotten bigger over time
J&J partnership, they could be waiting for rotor cuff, tennis elbow results, 3-6 month results due sometime this quarter. We all know how good Ortho-ATI is prepared to surgery. Lets hope our management team can pull off another partnership like Striate+, 100 million in the bank, another 25 year revenue stream, should lift our share price above 50 cents lol.
Throw in Remplir, Ortho-ACL ( Rope ) and its too the moon.
Ann: OrthoATI Tendon Clinical Study Success, page-211
Add OCC (ASX) to my watchlist
 (20min delay)
|
|||||
|
Last
36.0¢ |
Change
-0.005(1.37%) |
Mkt cap ! $75.35M | |||
| Open | High | Low | Value | Volume |
| 36.0¢ | 36.0¢ | 36.0¢ | $19.56K | 54.33K |
Buyers (Bids)
| No. | Vol. | Price($) |
|---|---|---|
| 1 | 25055 | 36.0¢ |
Sellers (Offers)
| Price($) | Vol. | No. |
|---|---|---|
| 37.0¢ | 56794 | 4 |
View Market Depth
| Last trade - 11.33am 04/07/2024 (20 minute delay) ? |
| OCC (ASX) Chart |